Reported impact
Business outcome
Natera nearly doubled data extraction, from 25 to 46 elements per test, enabling more accurate patient care, and it achieved a 150% cost reduction in data processing. But, its work is far from over. Key reported metrics include Natera nearly doubled data extraction, from 25 to 46 elements per test, enabling more accurate patient care, and it achieved a 150% cost reduction in data processing.; Natera’s identified over 200 potential use cases for AI implementation with personalized healthcare delivery.; The Signatera test is able to detect cancer recurrence 6-9 months earlier than standard imaging, so imagine what’s possible with further innovation..
- Cost Reduction
- Customer Experience
- Productivity Improvement
- Speed to Market
Solution
Discover how Natera, a pioneer in cell-free DNA testing, used AWS to create a robust data and analytics platform and democratize data to deliver crucial tailored medical care for patients worldwide. Every year, over two million patients in the U.S. discover they have cancer for the first time, with over eighteen million patients suffering globally (source: National Institutes of Health World Health Organization ). In the case of Brent, a young husband and father sought care following a mountain bike accident that caused pain and discomfort. Unexpectedly, a test revealed atypical cells, and further examination found tumors. After their removal and biopsy, Brent was diagnosed with stage three bladder cancer. He started chemotherapy right away. As part of his treatment plan, Brent’s oncologist introduced him to Natera’s Signatera testing, which tracks cancer indicators over time.
Data flow
Source data is ingested through Amazon Textract, stored or indexed in Amazon RDS, processed with Amazon SageMaker, Amazon Bedrock, Claude 3, coordinated by AWS Step Functions, AWS HealthOmics, and delivered through Amazon Q.